2018年11月10~12日，美国心脏协会科学年会（AHA 2018）将于美国-芝加哥召开。3天的学术日程将为广大临床医生和研究人员提供心血管领域的最新科研动态和临床实践指导。本届会议不乏亮点，2018年胆固醇临床实践指南将在主会场重磅发布，28项最新临床试验揭晓结果，此外，主题演讲、前沿科学峰会等专场也将为参会者带来不一样的精彩内容。了解更多内容，请点击左下角“阅读原文”，下载AHA 2018大会最终日程。
胆固醇指南重磅发布
11月10日，10:45 AM - 12:00 PM，Main Event I
2018 Cholesterol Clinical Practice Guidelines
2018年胆固醇临床实践指南
最新临床试验
LBS.01 - Answers to Critical Questions in Cardiovascular Prevention
Saturday， November 10， 2018， 2:00 p.m.–3:15 p.m. Main Event I
VITAL
The VITamin D and OmegA-3 TriaL: Principal Results for Vitamin D and Omega-3 Fatty Acid Supplementation in the Primary Prevention of Cardiovascular Disease and Cancer
VITamin D和OmegA-3试验：维生素D和Omega-3脂肪酸补充剂在心血管疾病和癌症一级预防中的主要结果
REDUCE-IT
The Primary Results of the REDUCE-IT Trial
REDUCE-IT试验的主要结果
EWTOPIA75
Ezetimibe in Prevention of Cerebro- and Cardiovascular Events in Middle- to High-risk， Elderly (75 Years Old or Over) Patients With Elevated LDL-cholesterol: A Multicenter， Randomized， Controlled， Open-label Trial
依折麦布在LDL-C升高的中高危，老年人（75岁或以上）患者心脑血管事件预防中的应用：多中心，随机，对照，开放标签试验
Cost-Effectiveness of Alirocumab Based on Evidence from a Large Multinational Outcome Trial: the ODYSSEY OUTCOMES Economics Study
基于大规模跨国试验证据的Alirocumab的成本效益：ODYSSEY经济学研究结果
LBS.02 - Novel Approaches to CV Prevention
Saturday， November 10， 2018， 3:45 p.m.–5:00 p.m. Main Event I
DECLARE – TIMI 58
The Dapagliflozin Effect on Cardiovascular Events (DECLARE)-TIMI 58 Trial
TIMI 58试验：达格列净对心血管事件的影响（DECLARE）
CIRT
The Cardiovascular Inflammation Reduction Trial (CIRT): Low Dose Methotrexate for the Prevention of Atherosclerotic Event
减少心血管炎症试验（CIRT）：低剂量氨甲喋呤预防动脉粥样硬化事件
AKCEA
Safety and Efficacy of AKCEA-APO(a)-LRx to Lower Lipoprotein(a) Levels in Patients with Established Cardiovascular Disease: A Phase 2 Dose-Ranging Trial
2期剂量范围试验：AKCEA-APO（a）-LRx对已诊断的心血管疾病患者降低脂蛋白（a）水平的安全性和有效性
Yoga-CaRe
Effectiveness Of A Yoga-based Cardiac Rehabilitation (yoga-care) Program: A Multi-centre Randomised Controlled Trial Of 4，014 Patients With Acute Myocardial Infarction From India
基于瑜伽的心脏康复（瑜伽护理）计划的有效性：来自印度的4014例急性心肌梗死患者的多中心随机对照试验
LBS.03 - Harnessing Technology and Improving Systems for Global Health
Saturday， November 10， 2018， 5:30 p.m.–6:45 p.m. Main Event II (s100)
BRIDGE CV PREVENTION
Effects of a Multifaceted Intervention to Narrow the Evidence-Based Gap in the Treatment of High Cardiovascular Risk Patients: the BRIDGE CV Prevention Cluster Randomized Trial
多方干预对缩小高心血管风险患者治疗中证据差距的影响：BRIDGE CV预防集群随机试验
BRIDGE Stroke
An International Cluster Randomized Quality-improvement Trial to Increase the Adherence to Evidence-based Therapies for Acute Ischemic Stroke and Transient Ischemic Attack Patients - the Bridge Stroke Trial
一项国际集群随机质量改进试验，旨在提高急性缺血性卒中和短暂性脑缺血发作患者循证治疗的依从性
AF-ALERT
Alert-Based Computerized Decision Support to Increase Anticoagulation Prescription Prevents Stroke and Myocardial Infarction in High-Risk Hospitalized Patients With Atrial Fibrillation: A Randomized， Controlled Trial
一项随机对照试验：基于警报的计算机化决策支持增加抗凝处方可预防高危住院房颤患者的卒中和心肌梗死
IMPACT-AF
Efficacy of Electronic Clinical Decision Support in Atrial Fibrillation: Results of the Integrated Management Program Advancing Community Treatment of Atrial Fibrillation
房颤电子临床决策支持的有效性：综合管理计划推进社区房颤治疗结果
mWellcare
Effectiveness of mHealth based Decision Support System for Integrated Management of Chronic Conditions in Primary Care: The mWellcare Trial
基于mHealth的决策支持系统对初级保健中慢病综合管理的有效性
LBS.04 - Preserving Brain & Heart in Acute Care Cardiology
Sunday， November 11， 2018， 9:00 a.m.–10:15 a.m. Main Event I
PRINCESS
Pre-hospital Resuscitation Intra-arrest Cooling Effectiveness Survival Study - the Princess Trial
Princess试验：院前复苏内部冷却治疗疗效的生存研究
Neuroprotect post-CA trial
Early Goal-directed Hemodynamic Optimization in Comatose Survivors After Out-of-hospital Cardiac Arrest: The Neuroprotect Trial
神经保护试验：院外心脏停搏后昏迷幸存者的早期导向性血流动力学优化
T-TIME
A Randomized， Double Blind， Placebo-Controlled， Parallel Group， Multicenter Clinical Trial of Low-Dose Adjunctive Alteplase During Primary PCI (T-TIME)
一项随机，双盲，安慰剂对照，平行组，多中心临床试验：低剂量阿替普酶辅助在急诊PCI期间（T-TIME）的应用
EARLY
Optimal Timing of Intervention in Non St-elevation Acute Coronary Syndromes Without Pretreatment
无预先治疗的非ST段抬高型急性冠状动脉综合征患者的最佳介入时机
Door to Unload (DTU) Trial
Mechanically Unloading the Left Ventricular and Delaying Reperfusion in Patients with Anterior ST-segment Elevation Myocardial Infarction: The Door to Unload Pilot Trial
DUT试验：ST段抬高型心肌梗死患者左心室机械性去负荷和再灌注延迟治疗
LBS.05 - Hot News in HF
November 11， 2018， 10:45 a.m.–12:00 p.m. Main Event I
PIONEER-HF Trial
Angiotensin Receptor-Neprilysin Inhibition in Patients Hospitalized With Acute Decompensated Heart Failure: Primary Results of the PIONEER-HF Randomized Controlled Trial
PIONEER-HF随机对照试验初步结果：血管紧张素受体-脑啡肽酶抑制剂在急性失代偿性心力衰竭住院患者中的应用
TRED-HF
Withdrawal of Pharmacological Heart Failure Therapy in Recovered Dilated Cardiomyopathy - A Randomised Controlled Trial (TRED-HF)
TRED-HF随机对照试验：扩张型心肌病患者的药物性心力衰竭戒断治疗
Effects of Rivaroxaban on Thrombotic Events in Heart Failure Patients with Coronary Disease and Sinus Rhythm
利伐沙班对冠心病和窦性心律失常患者血栓事件的影响
The EMPA-Heart Trial
EMPA-HEART Cardiolink-6 Trial: A Randomized Trial Evaluating The Effect Of Empagliflozin On Left Ventricular Structure， Function And Biomarkers In People With Type 2 Diabetes (T2D) And Coronary Heart Disease
EMPA-HEART Cardiolink-6试验：一项评估恩格列净对2型糖尿病（T2D）和冠心病患者左心室结构，功能和生物标志物影响的随机试验
Cardiac Remodeling following Ligation of Arteriovenous Fistula in Stable Renal Transplant Recipients: A Randomised Controlled Study
一项随机对照研究：在稳定的肾移植受者中结扎动静脉瘘后的心脏重构
LBS.06 - Late Breaking Science in Coronary Revascularization
Sunday， November 11， 2018， 5:30 p.m.– 6:45 p.m. Main Event II (s100)
REGROUP
Endoscopic Vein Harvest for Coronary Bypass Surgery in a Randomized Multicenter Trial With Long-Term Follow-up
随机多中心长期随访试验：冠状动脉旁路移植术中内镜下静脉采集
FREEDOM Follow-On Study
Long-term Survival following Multivessel Revascularization in Patients with Diabetes: the FREEDOM Follow-On Study
FREEDOM Follow-On 研究：糖尿病患者多支血管血运重建术后的长期生存率
TiCAB
A Randomized， Double-blind Study Of Ticagrelor Versus Aspirin In Patients Undergoing Coronary Bypass Surgery
冠状动脉旁路手术患者替格瑞洛与阿司匹林比较的随机双盲研究
ISAR TEST 4
Ten-Year Clinical Outcomes After Coronary Drug-Eluting Stents with Biodegradable or Permanent Polymer Coating: Results from the Randomized ISAR-TEST 4 Trial
随机ISAR-TEST 4试验结果：使用可生物降解或永久性聚合物涂层的冠状动脉药物洗脱支架后的十年临床结果
Intramyocardial Injection of Mesenchymal Precursor Cells in Left Ventricular Assist Device Recipients: Impact on Myocardial Recovery and Morbidity
左心室辅助装置植入患者心肌内注射间充质前体细胞对其心肌恢复和发病率的影响